Ken Fisher's BMRN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 35,480 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $2 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in BMRN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 18,181 shares. Largest reduction occurred in Q1 2025, reducing 393 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +190 | Add 0.54% | 35,480 | $56.49 |
| Q4 2025 | +3,564 | Add 11.23% | 35,290 | $59.43 |
| Q3 2025 | +18,181 | Add 134.23% | 31,726 | $54.16 |
| Q2 2025 | -28 | Reduce 0.21% | 13,545 | $54.97 |
| Q1 2025 | -393 | Reduce 2.81% | 13,573 | $70.69 |
| Q4 2024 | +420 | Add 3.10% | 13,966 | $65.73 |
| Q3 2024 | +122 | Add 0.91% | 13,546 | $70.29 |
| Q2 2024 | -75 | Reduce 0.56% | 13,424 | $82.34 |
| Q1 2024 | +9 | Add 0.07% | 13,499 | $87.34 |
| Q4 2023 | +13,490 | New Buy | 13,490 | $96.42 |
Ken Fisher's BioMarin Pharmaceutical Investment FAQs
Ken Fisher first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q4 2023, acquiring 13,490 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held BioMarin Pharmaceutical Inc. (BMRN) for 10 quarters since Q4 2023.
Ken Fisher's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q3 2025, adding 31,726 shares worth $1.72 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 35,480 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $2 M.
As of the Q1 2026 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 35,480 shares, as reported at the end of Q1 2026.